Bookmark Site
MEASUREcme banner  

MEASUREme™ Introduces Live CME Lectures Online!

Earn 1 AMA PRA Category 1 Credit™ from your home or office when YOU have time by participating in On Demand Web seminars, presented by expert faculty.

Lecture 1: Evidence-Based Clincal Strategy: The Patient With Bipolar Disorder

Upon completion of this activity, the participants should be able to:

  • Screen patients for bipolar disorder and associated comorbidities with appropriate techniques and tools
  • Differentiate bipolar disorder from other psychiatric conditions
  • Describe effective pharmacologic and nonpharmacologic treatment strategies
  • Recognize the issues surrounding the use of antidepressants in bipolar disorder

Lecture 2: Management of Medical and Psychiatric Comorbidities in Patients with Bipolar Disorder

Upon completion of this activity, the participants should be able to:

  • Screen patients with bipolar disorder for commonly associated psychiatric and medical comorbidities
  • Discuss effective treatment strategies for different psychiatric and medical bipolar comorbidities

Content Developed By Educational Review Board

Click here for Educational Review Board

CME Information

Needs Statement/Target Audience

Bipolar disorder is a devastating psychiatric disease associated with significant morbidity and mortality, and current epidemiology supports the estimate of 5% for the prevalence of bipolar disorder in the general population. Bipolar disorder is not a single disease state, but rather exists as a continuum of more subtle mental state changes. It is a chronic disease, characterized by depressive, manic or hypomanic, and mixed episodes. This psychiatric syndrome is often confused with unipolar depression, as patients with bipolar disorder spend the majority of their symptomatic time in a depressed rather than manic state. Comorbidities, including personality disorders, substance and alcohol abuse or dependence, and anxiety disorders, further complicate the assessment and treatment of this disease. As such, this activity has been planned in accordance with the need to provide psychiatrists and other health care providers with several continuing and emerging areas of importance in the diagnosis and treatment of bipolar disorder.

Release/Expiration Dates

This activity is eligible for CME credit from October 2007 through October 31, 2008.

Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The France Foundation designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure

It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty participating in this activity will disclose to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a faculty member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity. Faculty disclosure can be found on the faculty biography.

Henry A. Nasrallah, MD, serves on the advisory boards for and/or receives speaking honoraria from Abbott Laboratories, AstraZeneca Pharmaceuticals, Janssen Pharmaceutica Products, Pfizer, and Vanda. He has received grant and research support from AstraZeneca Pharmaceuticals, Janssen Pharmaceutica Products, Pfizer, and Sanofi.

Stephen M. Strakowski, MD, has served on speakers bureaus for AstraZeneca Pharmaceutical and Bristol- Myers Squibb. He has received grants from AstraZeneca Pharmaceuticals, Eli Lilly and Company, Forest Laboratories, Nutrition 21 Inc., Bristol-Myers Squibb, Martek Biosciences, Janssen, Repligen and Pfizer and has served as consultant for Eli Lilly and Company, Tikvah, and Pfizer.

Disclaimer

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and AstraZeneca Pharmaceuticals assume no liability for the information herein.

Commercial Support Acknowledgement

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

MEASURE Minutes
Bipolar Disorder and Substance Abuse Comorbidities - Fall 2007
Stephen M. Strakowski, MD, explains drug and alcohol use associated with bipolar disorder.(more)

Newsletter Archive

MEASURE Minutes
What's New

» MEASUREme™ 2008 Dinner Meeting Series
From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder
Earn 1 AMA PRA Category 1 Credit™

» MEASURE™ Resource Module - Online CME
Slides, interactive patient cases, and more...all focused on bipolar disorder

» NEW! MEASUREme™ On Demand CME Lectures
Earn 1 AMA PRA Category 1 Credit™ from your home or office when YOU have time by participating in On Demand Web seminars presented by expert faculty.

© 2007 The France Foundation Contact Us
Terms of Use | Privacy Statement
 
 
Download file:
Right click and choose "Save Target As" to download this file.
Download file:
Right click and choose "Save Target As" to download this file.